Yufei Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yufei Yang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Deqiang Wang
Department of Oncology, Digestive Disease Institute & Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, China
1 shared publication - Fen Xiong
Department of Medical Oncology, Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China
1 shared publication - Ting Zhu
Institute of Oncology, Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China
1 shared publication - Xiao Yuan
Institute of Oncology, Affiliated Hospital of Jiangsu University, Zhenjiang, China
1 shared publication - Xu Wang
Department of Radiation Oncology, Institute of Oncology, Affiliated Hospital of Jiangsu University, Zhenjiang, China
1 shared publication - Xuehan Qiao
Department of Medical Oncology, Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China
1 shared publication
Latest Publications
- Open Access
ACSL3 and ACSL4, Distinct Roles in Ferroptosis and Cancers
The long-chain fatty acyl CoA synthetase (ACSLs) family of enzymes contributes significantly to lipid metabolism and produces acyl-coenzyme A by catalyzing fatty acid oxidation. The dysregulation of ACSL3 and ACSL4, which belong to the five isoforms of ACSLs, plays a key role in cancer initiation, development, metastasis, and tumor immunity and may provide several possible therapeutic strategies. Moreover, ACSL3 and ACSL4 are crucial for ferroptosis, a non-apoptotic cell death triggered by the accumulation of membrane lipid peroxides due to iron overload. Here, we present a summary of the current knowledge on ACSL3 and ACSL4 and their functions in various cancers. Research on the molecular mechanisms involved in the regulation of ferroptosis is critical to developing targeted therapies for cancer.
Open AccessACSL3 and ACSL4, Distinct Roles in Ferroptosis and Cancers
The long-chain fatty acyl CoA synthetase (ACSLs) family of enzymes contributes significantly to lipid metabolism and produces acyl-coenzyme A by catalyzing fatty acid oxidation. The dysregulation of ACSL3 and ACSL4, which belong to the five isoforms of ACSLs, plays a key role in cancer initiation, development, metastasis, and tumor immunity and may provide several possible therapeutic strategies. Moreover, ACSL3 and ACSL4 are crucial for ferroptosis, a non-apoptotic cell death triggered by the accumulation of membrane lipid peroxides due to iron overload. Here, we present a summary of the current knowledge on ACSL3 and ACSL4 and their functions in various cancers. Research on the molecular mechanisms involved in the regulation of ferroptosis is critical to developing targeted therapies for cancer.